Meet the Team

Damien Hancox

Co-Founder & Director

Damien Hancox is an experienced entrepreneur who specialises in identifying opportunities in emerging trends and builds businesses around the opportunities they represent. He started his career at a young age in the telecoms sector before moving into international retail development. Between 2001-2006 he built and sold a multi-million pound telecoms business. He has also successfully introduced brands to emerging markets and fast tracked their exposure for his customers and partners. He specialises in logistics and management, and bringing his experience of emerging markets together with that of imminent developments.

Jennifer Von Strohe

Marketing Director

As a global marketing leader with 20 years of experience, Jennifer is known for driving brand growth, maximizing operational excellence and delivering financial performance. For the past 7 years she has consulted as a marketing specialist for top brands in the gaming, fintech and FMCG industries, passionately executing all facets of the brand and customer journey to achieve increased revenues, global expansion and IPOs. Previous to this she served as the Global Marketing and PR Director for FTSE 250, online gaming leader, 888holdings, where she was responsible for the company’s B2C branding and advertising operations. During her tenure at 888, she executed and led the corporate rebranding of the B2C division and spearheaded the diversification of the advertising and communication strategies which resulted in triple digit growth in customer acquisition, revenues and a 600% increase to the stock price. Von Strohe holds a double major Marketing and Management with a minor in Psychology Bachelors of Arts degree from Texas State University and currently resides in London, UK

Hoji Alimi

Scientific Director

Mr. Alimi has been working with HOCl for more than 20 years. He founded and served as the CEO and Chairman of Oculus Innovative Sciences, Inc. in 2002. The company focused on the development of a Hypochlorous Acid (“HOCl”) based topical anti-infective drug as well as device related applications. The company completed a successful controlled randomized double-blind phase II trial for improvement or cure of infection in diabetic ulcers. The company achieved multiple CE mark approvals and seven 510(k) FDA clearances as well as other regulatory approvals for its primary platform drug in multiple foreign territories. In 2007, the company became public and traded on NASDAQ. The company had operations in the U.S., Europe, Mexico, and distribution partners around the world. Mr. Alimi is the CEO and founder of Spectrum Antimicrobials Inc. He holds more than 36 patents in areas of anti-infectives, surgical, wound care and manufacturing of specific drugs and devices. Mr. Alimi has raised more than $170,000,000 in capital for various ventures.

Dr Colin Petts

Techinical & Engineering Advisor

Dr. Colin Petts holds a PhD in Electrical and Electronic Engineering from University College London. He has worked in high technology industries for nearly 40 years. During that time, he had a variety of roles including Research and Development, Engineering and Operations Management but always maintained a passion for Science and Technology.  He has experience of business restructuring, unit integration and change management. For the last two decades he has provided regulatory, product development and manufacturing assistance to over 250 organizations from the UK and around the world.  

Richard Jones

General Manager

Richard Jones has had a career in logistics and operational management for both the public and the private sector. He was a Fleet Manager at Littlewoods Retail Group, and has held similar roles in local Government. With a proactive, strong customer focus and a can-do approach he is an experienced general manager with particular expertise in transport and logistics, project management and new systems development and delivery.

Ben Hibbert

Operations Director

Ben Hibbert is a Project Director of nearly two decades, he holds a BSc in Quantity Surveying from the University of Salford and is also a Chartered Surveyor with many years of experience delivering complex schemes around the UK. Having led projects with values up to £250m in a range of sectors including Education, Manufacturing, Logistics, Research, Health and Retail, Ben has fine-tuned the art of taking a project from inception to delivery, and believes that strong relationships and managing communication between all parties sit at the heart of successful implementation.

Susy Castro

Communications Executive

Susy Castro graduated from Parsons School of Design in New York and specialises in communications, design and marketing. She has worked in many countries around the world where she has developed the skills to understand different markets and client needs. She launched and operated her own successful fashion brand for over five years in Amsterdam before selling it to launch a creative agency in London. She has worked with an array of clients ranging from an NGO in Africa to a tech start up in London. She now specialises in developing and launching brands for fast moving business start-ups. 

Des Grech

Sales Director

Des Grech has predominantly worked in the finance industry and was authorised and regulated by the Financial Services Authority for a number of years and has over 25 years of experience building and leading the sales teams and revenue streams for a number of companies. In his last two roles Des was responsible for the global retail and institutional teams who generated over $1 billion in revenue which resulted in acquisitions for both companies.

Carl Krueger

Crowd Safety Management Consultant

Carl Krueger recently retired as Chief Superintendent from Merseyside Police after 30 years service. Carl was educated at the University of Liverpool and has a Masters Degree in Management. For 13 years he was a Police Football Commander working with two Premier league clubs and latterly the England team in domestic, European and international competitions. Since retirement he has worked in the football industry as an Operations Manager and Safety Officer for a football league club whilst also performing the role of FA Crowd Safety Adviser for Liverpool FC away matches in the UEFA Champions League. He is currently working with the Qatari Police as a training consultant preparing staff for the 2022 World Cup.

Professor Denis F. Kinane

Medical and Scientific Advisor

Professor Kinane has been in academia and research for 35 years, directing research centres, schools and institutes at 5 Universities, in Europe and the USA. Currently, he is Professor of Immunology at the University of Geneva and on the board of several US, Chinese, Taiwanese and UK companies specialising in Health Care provision. In addition, he is Medical Director, Science Director and Compliance Officer for several companies (UK, Taiwanese and Korean) specialising in the Health and Diagnostic Sector. Professor Kinane Is also CEO of his own pharma start-up TheraJect which specializes in slow release anti-inflammatories. Through interest and commitment, he positions himself at the interface of human scientific research and business, hoping to bring the latest medical innovations to fruition. Recently he has been using his skills and experience to bring together business, health, government and higher education to address the COVID pandemic, by co-founding the charity, Project-Little-Boats. He continues to publish academic research as well as editing and reviewing grants and papers and performing due diligence on medical products.

Aziz McMahon

Strategic Advisor

Aziz McMahon is a finance professional, angel investor and cornerstone investor in SpectrumX. He has over 20yrs experience in both investment banking and macro advisory and is currently employed by one of the largest investment banks in the world. He holds a masters degree in applied econometrics from Trinity College Dublin.

Earl of Shrewsbury & Talbot

Commercial Advisor

Charles Shrewsbury is a businessman and an active elected hereditary member of the House of Lords where his interests include Commerce and Industry, Agriculture and Rural issues. A former Director and Deputy Chairman of a major Building Society and a Past President of the Building Societies Association, he has also served as an NED on a number of Boards. He is Senior Advisor to DWF Law Plc, the largest LSE quoted legal services business. He acts in an advisory role for a number of major and medium sized businesses, both quoted and private. As he has for many years, he continues to promote British commerce and manufacturing industry both at home and abroad. He acts as an advisor to a number of high net worth individuals. Over 10 years from 1995, he purchased and assembled Cauldon Low Quarries, a major limestone quarry in North Staffordshire, selling to the Crown Estate in 2005. He is executive President of the Association of Manufacturers of Power Systems (AMPS).

Gordon Buchanan

Medical Advisor

Gordon Buchanan is a Consultant Surgeon, specialising in Colorectal and General surgery, with particular interests in minimally invasive cancer surgery, hernias as well as proctological disorders. Gordon began studying medicine at St Thomas’ Hospital, London over 30 years ago and has been in Consultant practice for almost 15 years. His MSc and MD research at St Mark’s Hospital, awarded by Imperial College and University of London assessed many areas of Complex anorectal fistula – he gained several prizes to visit other centres in USA (Lahey, Mayo and Cleveland clinics) and Hong Kong and undertook training fellowships at St Mark’s Hospital, Mount Sinai in Toronto as well as Laparoscopic Colorectal fellowships in UK. He has lectured internationally as well as operated by live link to train surgeons in Europe in Coloproctology. He regularly trains and teaches through the Royal College of Surgeons, Imperial College and on other invited courses. He has sat on the Council of both Association of Coloproctology of Great Britain and Ireland and Royal Society of Medicine Section of Coloproctology, where he is currently Vice President. Gordon has published over 50 peer reviewed papers, helped run and contributed to multicentre clinical trials as well as contributing to books, national guidelines and examining MD theses. Gordon has continued to work throughout the pandemic across the NHS and private sectors, and is an advocate for minimally invasive techniques, particularly in methods that hasten wound healing and minimise infection.

Professor Justin Stebbing

Medical Advisor

Professor Justin Stebbing specialises in a range of malignancies, their treatment with immunotherapy (breast, GI and lung and clinical trials), having originally trained in medicine at Trinity College Oxford, where he gained a first class degree. After completion of junior doctor posts in Oxford, he undertook training and a residency programme at The Johns Hopkins Hospital in the US, returning to London to continue his career in oncology at The Royal Marsden and then St Bartholomew’s Hospitals. Professor Stebbing’s original PhD research investigated the interplay between the immune system and cancer; he was appointed a senior lecturer in 2007, and a Professor in 2009.

Professor Stebbing has published over 600 peer-reviewed papers in journals such as the Lancet, New England Journal, Blood, the Journal of Clinical Oncology, Annals of Internal Medicine, as well as writing regularly for national newspapers and presenting new data on optimal cancer therapies at the major international conferences. His focus at Imperial is on new therapies in cancer, and the systemic management of patients with solid malignancies including a number of new biomarker-based approaches, with an emphasis on circulating tumour cells and cell free DNA. His laboratory work is concentrated on new druggable target discovery and gene regulation examining the role of non-coding RNAs in stem cells.

Gordon Buchanan

Medical Advisor

Gordon Buchanan is a Consultant Surgeon, specialising in Colorectal and General surgery, with particular interests in minimally invasive cancer surgery, hernias as well as proctological disorders. Gordon began studying medicine at St Thomas’ Hospital, London over 30 years ago and has been in Consultant practice for almost 15 years. His MSc and MD research at St Mark’s Hospital, awarded by Imperial College and University of London assessed many areas of Complex anorectal fistula – he gained several prizes to visit other centres in USA (Lahey, Mayo and Cleveland clinics) and Hong Kong and undertook training fellowships at St Mark’s Hospital, Mount Sinai in Toronto as well as Laparoscopic Colorectal fellowships in UK. He has lectured internationally as well as operated by live link to train surgeons in Europe in Coloproctology. He regularly trains and teaches through the Royal College of Surgeons, Imperial College and on other invited courses. He has sat on the Council of both Association of Coloproctology of Great Britain and Ireland and Royal Society of Medicine Section of Coloproctology, where he is currently Vice President. Gordon has published over 50 peer reviewed papers, helped run and contributed to multicentre clinical trials as well as contributing to books, national guidelines and examining MD theses. Gordon has continued to work throughout the pandemic across the NHS and private sectors, and is an advocate for minimally invasive techniques, particularly in methods that hasten wound healing and minimise infection.

Derek Brown

Commercial Advisor

Derek is a highly professional and entrepreneurial international executive with extensive experience of commercial management, sales and marketing, supply chain and bringing complex products to market. He has over 33-years global pharmaceutical corporate experience and has worked with some of the largest companies in the world, most recently as Hospital Director for Accord UK Ltd, the biggest speciality company in the UK where he launched a number of generic, branded and biosimilar products. Derek brings a wealth of expertise in launching products across Europe and developing new structures, supply chain solutions and partner agreements to expedite uptake of new entrant products.

Dr Alexander Nill

Commercial Advisor

Alexander Nill is an experienced investment banker and a serial entrepreneur.  Over the last 27 years, he has been involved as an investor in more than 60 transactions, many of them of international scope. He was a shareholder in Toptier software which sold to SAP, he was an early shareholder in Shazam and was directly or indirectly involved in 16 IPO’s on the Deutsche Neue Markt Börse. He is a Co-Founder and board member of Sparta AG (a Hamburg based public corporate finance and investment company) and a Co-Founder and Chairman of the Board of IQ Capital AG (a Frankfurt based venture capital firm with offices in San Francisco, Zurich, Singapore, and London). He is taking an active approach managing the investment portfolio of his companies, Dr. Nill serves on several boards of directors.  He is a director of IQ Finance plc (a financial services company) and is currently Chairman of f Athena Invest Gmbh. He is the co-owner of OTTO Stadtlander GmbH the leading commodity trader for long and extra long staple Cotton and has further interest in precious metal trading.

 

Interested In Learning More?